BSECompany Update2d ago · 27 Jul 2026, 05:58 pm
Please find attached herewith Intimation for Investors Call Scheduled to be held on 4th August, 2026.
Alembic Pharmaceuticals Ltd · 533573
✦ AI SummaryResults
Alembic Pharmaceuticals Ltd has announced a conference call to discuss its Q1 FY27 unaudited financial results on August 4, 2026. The call will be held at 5:30 P.M. IST and can be accessed through a registration link or by dialing into a conference line.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Attachments (1)
📄pdf
Download →
a3b31d3d-fd65-4fa9-8694-360d48a87d87.pdf
View document text
Date: 27th July, 2026
To, To,
The Manager, The Manager,
BSE Limited National Stock Exchange of India Ltd.
P. J. Towers, Dalal Street, ‘Exchange Plaza’, Bandra Kurla Complex,
Fort, Mumbai – 400 001 Bandra (E), Mumbai – 400 051
BSE Scrip Code: 533573 NSE Symbol: APLLTD
Dear Sir/Madam,
Sub: Schedule of Post Results Conference Call
The exchange is hereby informed that the Company will hold Post Results Conference
Call only for analysts / institutional investors on Tuesday, 4th August, 2026 as per the
enclosed details.
We request you to kindly take the same on record.
Thanking you,
Yours faithfully,
For Alembic Pharmaceuticals Limited
G. Krishnan
Chief Financial Officer
Encl.: A/a
ALEMBIC PHARMACEUTICALS LIMITED
REGD. OFFICE: ALEMBIC ROAD, VADODARA - 390 003. ● TEL: (0265) 2280550, 2280880 ● FAX: (0265) 2281229
Website : www.alembicpharmaceuticals.com ● E-mail : alembic@alembic.co.in ● CIN : L24230GJ2010PLC061123
27th July, 2026
CONFERENCE CALL
We are organizing a conference call with our Senior Management Team Members to
discuss the Company’s Q1 FY27 Unaudited Financial Results on Tuesday, 4th
August, 2026 at 5:30 P.M. IST.
Details of the conference call are as under:
Time: 5:30 P.M. IST on Tuesday, 4th August, 2026
Option 1:
To enable participants to connect to the conference call without having to wait for an
operator, please register at the below mentioned link:
Click →: Diamond Pass Registration
You will receive dial in numbers, passcode and a pin for the concall on the registered
email address provided by you. Kindly dial into the call on the conference call date and
use the passcode & pin to connect to the call.
Option 2:
Conference dial-in:
Universal Access Number +91 22 6280 1411
+91 22 7115 8312
India National Toll Free 1 800 120 1221
Number
International Toll Free USA 1866 746 2133
Number UK 080 810 11573
Singapore 800 101 2045
Hong Kong 800 96 4448
For further information contact:
Isha Lamba
Phone: +91 22-66951652
Email: isha.lamba@alembic.co.in
ALEMBIC PHARMACEUTICALS LIMITED
REGD. OFFICE: ALEMBIC ROAD, VADODARA - 390 003. ● TEL: (0265) 2280550, 2280880 ● FAX: (0265) 2281229
Website : www.alembicpharmaceuticals.com ● E-mail : alembic@alembic.co.in ● CIN : L24230GJ2010PLC061123